Oral cavity adjuvant therapy (OCAT) -a phase III, randomized controlled trial of surgery followed by conventional RT (5 fr/wk) versus concurrent CT-RT versus accelerated RT (6fr/wk) in locally advanced, resectable, squamous cell carcinoma of oral cavitySarbani Ghosh Laskar, D'Cruz Anil, Gouri Pantvaidya et al.|European Journal of Cancer|2022Cited by 29
Impact of Adjuvant Treatment in pN3 Penile CancerPallavi Khurud, Vedang Murthy, Rahul Krishnatry et al.|Clinical Oncology|2021Cited by 14
Bone metastases in prostate cancer – Gallium-68–labeled prostate-specific membrane antigen or Fluorine 18 sodium fluoride PET/computed tomography – the better tracer?Archi Agrawal, Venkatesh Rangarajan, Aravintho Natarajan et al.|Nuclear Medicine Communications|2022Cited by 11
Exploring the role of systemic therapy in adult adrenocortical carcinoma: A single-center experienceKumar Prabhash, Nilesh P. Sable, Akhil Kapoor et al.|Cancer Research Statistics and Treatment|2020Cited by 3
Six-year follow-up from the weekly-three-weekly study comparing cisplatin once-a-week to once-every-three-weeks as concurrent chemoradiation for locally advanced head and neck squamous cell carcinoma.Vanita Noronha, Kumar Prabhash, Vijay Patil et al.|Journal of Clinical Oncology|2022Cited by 3